Eikon Clocks Largest IPO Since 2024, Generate Follows as IPO Tap Opens

By /

Analysts are cautiously optimistic about an IPO rebound for biopharma. BioSpace is keeping track of companies that seek to trade on the public markets this year.

Scroll to Top